Patrick Collins Selected Research

risankizumab

8/2020

Risankizumab-Aggravated Crusted Scabies in a Patient with Down Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrick Collins Research Topics

Disease

3	Neoplasms (Cancer) 01/2022 - 03/2016
3	Human Influenza (Influenza) 08/2011 - 03/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2011 - 06/2007
2	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 12/2021
2	Fibrosis (Cirrhosis) 01/2016 - 01/2016
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2016 - 01/2016
2	Atherosclerosis 07/2002 - 07/2002
1	Carcinogenesis 01/2022
1	Bites and Stings (Sting) 01/2022
1	Alcoholic Fatty Liver 12/2021
1	Obesity 12/2021
1	Cytokine Release Syndrome 11/2021
1	COVID-19 01/2021
1	Lymphadenopathy 12/2020
1	Adenocarcinoma 08/2020
1	Breast Neoplasms (Breast Cancer) 08/2020
1	Down Syndrome (Down's Syndrome) 08/2020
1	Neoplasm Metastasis (Metastasis) 08/2020
1	Extramammary Paget Disease (Paget Disease, Extramammary) 08/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2020
1	Scabies (Sarcoptic Mange) 08/2020
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2017
1	Starvation 01/2017
1	Disease Progression 03/2016
1	Thrombosis (Thrombus) 01/2011
1	Vascular Diseases (Vascular Disease) 04/2009
1	Hypertension (High Blood Pressure) 04/2009
1	Intermittent Claudication 07/2006
1	Inflammation (Inflammations) 07/2006
1	Atherosclerotic Plaque (Atheroma) 07/2005
1	Schizophrenia (Dementia Praecox) 02/2003
1	Dyslipidemias (Dyslipidemia) 07/2002

Drug/Important Bio-Agent (IBA)

3	LipidsIBA 01/2017 - 07/2002
2	Polysaccharides (Glycans)IBA 01/2016 - 01/2016
2	Galectin 3 (LGALS3)IBA 01/2016 - 01/2016
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2016 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2016 - 02/2003
2	HomocysteineIBA 01/2011 - 04/2009
1	Small Interfering RNA (siRNA)IBA 06/2022
1	Caspase 8 (Caspase-8)IBA 01/2022
1	CytokinesIBA 01/2022
1	AntigensIBA 01/2022
1	LigandsIBA 01/2022
1	Dual Specificity Phosphatase 3IBA 12/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Oxygen (Dioxygen)IBA 08/2020
1	InterleukinsIBA 08/2020
1	Methotrexate (Mexate)FDA LinkGeneric 08/2020
1	risankizumabIBA 08/2020
1	SolutionsIBA 08/2020
1	Bile Acids and Salts (Bile Acids)IBA 01/2017
1	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 03/2016
1	AsparagineIBA 03/2016
1	Proteins (Proteins, Gene)FDA Link 03/2016
1	Galectin 1 (LGALS1)IBA 01/2016
1	coumarinIBA 01/2016
1	pirfenidoneIBA 01/2016
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2016
1	Hemagglutinins (Hemagglutinin)IBA 08/2011
1	Neutralizing AntibodiesIBA 08/2011
1	IntegrinsIBA 01/2011
1	Cysteine (L-Cysteine)FDA Link 01/2011
1	Cell Adhesion MoleculesIBA 01/2011
1	Aspartic Acid (Aspartate)FDA Link 07/2010
1	Neuraminidase (Sialidase)IBA 07/2010
1	Oseltamivir (Tamiflu)FDA Link 03/2010
1	2,5-dichloro-4-bromophenol (B 2)IBA 03/2010
1	antineoplaston A10 (A 10)IBA 03/2010
1	Apolipoproteins B (ApoB)IBA 04/2009
1	Triglycerides (Triacylglycerol)IBA 04/2009
1	ApoproteinsIBA 04/2009
1	LDL CholesterolIBA 04/2009
1	HDL CholesterolIBA 04/2009
1	CholesterolIBA 04/2009
1	Cholesterol Ester Transfer ProteinsIBA 06/2007
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2006
1	CollagenIBA 07/2005
1	oxidized low density lipoproteinIBA 07/2005
1	Proteoglycans (Proteoglycan)IBA 07/2005
1	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2003
1	Insulin (Novolin)FDA Link 02/2003
1	Glucose (Dextrose)FDA LinkGeneric 02/2003
1	ChylomicronsIBA 07/2002
1	Messenger RNA (mRNA)IBA 07/2002
1	Apolipoproteins E (ApoE)IBA 07/2002
1	microsomal triglyceride transfer proteinIBA 07/2002

Therapy/Procedure

4	Therapeutics 06/2022 - 07/2006
1	Immunotherapy 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2021
1	Drug Therapy (Chemotherapy) 12/2020
1	Topical Administration 08/2020
1	Condoms (Condom) 01/2017
1	Oral Administration 01/2016